CEO Total Pay
$12.7M
FY2021 Summary Compensation
Open-data reference.
ABIOMED INC, a measuring instruments company, reported a CEO-to-worker pay ratio of 96:1 in FY2021. CEO received total compensation of $12.7M, while the median employee earned $131,893 annually. This is below the Measuring Instruments industry median of 108:1 across 98 companies. Data sourced from SEC EDGAR proxy (DEF 14A) filings.
Detailed breakdown not available.
| Component | Amount (USD) |
|---|---|
| Base Salary | — |
| Bonus | — |
| Stock Awards | — |
| Option Awards | — |
| Non-Equity Incentive Plan | — |
| Pension Value Change | — |
| Other Compensation | — |
| Total Compensation | $12.7M |
Source: SEC EDGAR Form DEF 14A — CIK 815094, FY2021 Summary Compensation Table.
ABIOMED INC's CEO-to-worker pay ratio of 96:1 means that earned 96 times more than the company's median employee in FY2021.
The median employee at ABIOMED INC earned $131,893 annually. At that wage, it would take a median employee approximately 96 years to earn what the CEO earned in a single year.
CEO Total Pay
$12.7M
FY2021 Summary Compensation
Pay Ratio
96:1
Near industry median
Disclosure Transparency
1.0/5
Limited pay component reporting
Under 17 CFR §229.402(v) (the Pay-Versus-Performance rule effective for fiscal years ending after December 16, 2022), issuers must reconcile Compensation Actually Paid (CAP) to Total Shareholder Return (TSR) over a multi-year window. The chart below visualizes the relationship between ABIOMED INC's reported CAP and TSR for FY2021.
ISS QualityScore and Glass-Lewis voting guidelines weight performance-linked share of pay. The CII (Council of Institutional Investors) recommends ≥50% of CEO pay be tied to multi-year performance metrics.
According to the 2021 DEF 14A proxy statement filed with the SEC, ABIOMED INC (, CIK 815094) reported CEO 's total compensation at $12.7M. That figure is an aggregate of base salary (N/A). The median employee at the firm — the reference point mandated by Section 953(b) of the Dodd-Frank Act — earned $131,893 over the same fiscal year, producing the headline CEO-to-worker pay ratio of 96:1 that this page tracks.
Context matters when reading this ratio. ABIOMED INC operates in the Measuring Instruments sector and is headquartered in DE. Across the Measuring Instruments industry (SIC 38), 98 SEC-reporting companies disclosed pay ratios in FY2023, with a median of 108:1 and an average of 168:1. Median industry CEO pay was $8.4M, so ABIOMED INC's $12.7M sits above that typical figure. That comparison is the fastest way to separate "the CEO is paid like peers" from "this company is an outlier."
Finally, a note on what these SEC numbers do and do not include. Total compensation reported under Item 402 of Regulation S-K reflects grant-date fair value for equity awards, not realized pay, so a CEO may eventually cash in more — or less — depending on stock performance and vesting. The pay ratio itself is calculated against a single median employee chosen under rules that allow statistical sampling, and companies may update methodology year to year. This proxy was filed on 2022-06-28; all figures on this page come directly from that public filing and can be verified against the DEF 14A on the SEC EDGAR system.
Read our methodology — how this data is sourced, computed, and verified.